Zevra Therapeutics (ZVRA) Return on Sales (2019 - 2026)
Zevra Therapeutics' (ZVRA) quarterly Return on Sales came in at 0.01% in Q1 2026, up 1.0% YoY from 0.01% in Q1 2025, and up 193.84% on a QoQ basis from 0.0% in Q4 2025.
Zevra Therapeutics (ZVRA) Return on Sales (2019 - 2026) Analysis & Trends
Zevra Therapeutics (ZVRA) has 8 years of Return on Sales data on file, last reported at 0.01% in Q1 2026.
- Quarterly Return on Sales rose 1.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 3.0% YoY) and the FY2025 annual result came in at 0.01%, up 5.0% from the prior year.
- Return on Sales improved to 0.01% in Q1 2026, from 0.0% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.03% in Q2 2025 to a low of 0.18% in Q2 2022.
- A 5-year average of 0.03% and a median of 0.02% in 2023 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2022 — Return on Sales retreated 18 bps — and 2023, when it increased 17 bps.
- Tracing ZVRA's Return on Sales over 5 years: stood at 0.01% in 2022, then dropped by 5 bps to 0.02% in 2023, then tumbled by 93 bps to 0.03% in 2024, then surged by 112 bps to 0.0% in 2025, then soared by 194 bps to 0.01% in 2026.
- The last three Return on Sales figures came in at 0.01% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Zevra Therapeutics | 671.75 Mn | 450.18 Mn | 38.18 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.01% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.03% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | -0.09% |
| Jun 30, 2024 | -0.05% |
| Mar 31, 2024 | -0.05% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.04% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -0.04% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.18% |
| Mar 31, 2022 | 0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |